The World Health Organization (WHO) has declared the escalating mpox outbreak a global public health emergency, following a surge in cases across Africa and emerging reports of infections in other regions, including Europe. The decision underscores the urgent need for coordinated global efforts to contain the spread of this viral disease, previously known as monkeypox.
Mpox primarily spreads through close physical contact with infected individuals or contaminated objects. The disease, characterized by flu-like symptoms and skin lesions, has recently evolved into a more virulent strain. This new variant has led to a higher fatality rate, currently ranging between 3-4%, according to WHO data.
The situation is particularly dire in Africa, where the outbreak has been most severe. The Africa Centres for Disease Control and Prevention (Africa CDC) has reported over 15,600 cases and 537 deaths across the continent in 2024 alone. The rapid increase in cases compared to previous years has alarmed health officials, who warn that the outbreak is far from under control.
In the Democratic Republic of the Congo (DRC), where health infrastructure is already weakened by ongoing conflicts and past epidemics like Ebola, the outbreak is causing significant strain. The WHO’s emergency declaration highlights the critical need for international support to bolster local health systems and prevent a humanitarian disaster.
The virus is endemic to parts of Central and West Africa, but the current outbreak has spread beyond the continent’s borders. Countries such as Sweden, Pakistan, and the Philippines have reported cases, raising concerns about global transmission. The WHO is particularly worried about the emergence of Clade 1b, a new and more transmissible strain of the virus that poses additional risks, especially to vulnerable populations like children and the elderly.
Efforts to combat the outbreak are being hampered by vaccine shortages. African nations, already grappling with limited healthcare resources, are facing difficulties in securing adequate supplies of the mpox vaccine, Jynneos. Denmark’s Bavarian Nordic, the manufacturer of the vaccine, has increased production in response to the WHO’s emergency declaration, aiming to produce up to 10 million doses by 2025. However, the challenge remains in distributing these vaccines effectively, particularly in conflict-ridden areas like North Kivu in the DRC.
Healthcare workers on the ground, including those from organizations like Doctors Without Borders (MSF), are working tirelessly to treat those infected and educate communities on prevention measures. However, they face significant obstacles, including logistical challenges and the dangers posed by ongoing conflicts in affected regions.
The WHO and other health authorities are calling for equitable vaccine distribution and increased investment in healthcare infrastructure, especially in Africa. The lessons learned from past epidemics, such as Ebola and COVID-19, are being applied to manage the current crisis, but experts warn that without swift and decisive action, the situation could deteriorate further.
In the meantime, public health officials continue to emphasize the importance of basic hygiene practices, such as regular hand washing and avoiding close contact with infected individuals, as crucial steps in preventing the spread of mpox.
As the world grapples with this latest health crisis, the global community is being urged to act quickly to prevent the outbreak from becoming an even greater threat. The WHO’s declaration is a call to action, reminding us of the interconnectedness of global health and the need for solidarity in the face of emerging threats.
Related Articles:
What is Mpox？why So Concerning?
Travelers Advised to Consider Mpox Vaccination Amid New
How to Prevent Mpox: A Comprehensive Guide
